London, United Kingdom Aug 20, 2024 (Issuewire.com) - EuroNoxx Medical Group Ltd and Allengers are excited to unveil a new strategic partnership that will see EuroNoxx become the exclusive distributor of Allengers' advanced medical devices across the United Kingdom. This collaboration represents a significant step forward in advancing healthcare through the introduction of groundbreaking technology to the UK market.
As part of this exclusive agreement, EuroNoxx Medical Group Ltd will bring Allengers' renowned imaging systems and diagnostic tools to hospitals and clinics throughout the UK. This partnership aims to provide healthcare professionals with state-of-the-art equipment to enhance patient care and improve clinical outcomes.
Announcing the Breast Cancer 2024 Symposium
In celebration of this landmark partnership, EuroNoxx Medical Group Ltd is thrilled to be a key sponsor and organiser of the upcoming Breast Cancer 2024 Symposium. This prestigious event, organised in conjunction with Koning Corporation, the London International Medical School, and
Allengers, will be a cornerstone event in the breast cancer care calendar.
The symposium will feature cutting-edge presentations on the latest advancements in breast cancer diagnostics, including insights into innovative technologies from Allengers and Koning Corporation. Participants will have the chance to engage with leading experts, take part in dynamic panel discussions, and explore future trends in breast cancer detection and treatment.
Dr Mandeep Goma, Managing Director of EuroNoxx Medical Group Ltd, expressed enthusiasm about the partnership, stating, “We are delighted to partner with Allengers to bring their exceptional technology to the UK. This agreement underscores our commitment to improving healthcare standards. The Breast Cancer 2024 Symposium is the perfect platform to showcase these advancements and drive meaningful conversations about the future of breast cancer care.”
Dr Rajiv Malhotra, CEO of Allengers, added, “Our collaboration with EuroNoxx Medical Group Ltd is an exciting development for us. We are eager to introduce our advanced technology to the UK market and contribute to the ongoing battle against breast cancer. We look forward to engaging with the healthcare community at the Breast Cancer 2024 Symposium and demonstrating how our innovations can make a difference.”
Event Details:
- Date: Saturday, 7 September 2024
- Time: 9:00 am - 5:00 pm
- Venue: Royal Society of Medicine, 1 Wimpole Street, London W1G 0AE
- Contact: +44 20 3642 1175 | symposium24@euronoxxmedical.com
This symposium promises to be a pivotal event for professionals and stakeholders in breast cancer care, offering a unique opportunity to engage with the latest innovations and foster collaborative progress.
For further details on the exclusive agreement with Allengers and the Breast Cancer 2024 Symposium, please reach out to EuroNoxx Medical Group Ltd at symposium24@euronoxxmedical.com.
About EuroNoxx Medical Group Ltd:
EuroNoxx Medical Group Ltd is at the forefront of advancing healthcare in the UK by providing innovative medical solutions. Specialising in the distribution of medical equipment and surgical devices, EuroNoxx is committed to supporting the NHS and private hospitals with cutting-edge technology and expert support.
About Allengers:
Allengers is a global leader in the design and manufacture of medical imaging and diagnostic equipment. Renowned for its commitment to innovation and quality, Allengers provides healthcare professionals with the tools necessary for exceptional patient care.
Media Contact:
Ed Beasley
Digital Marketing Manager
EuroNoxx Medical Group Ltd
Contact: +44 20 3642 1175 | info@euronoxxmedical.com
www.euronoxxmedical.com
Media Contact
euronoxx-medical-group info@euronoxxmedical.com 02036421175 35 Berkeley Square, Mayfair, London, UK, W1J 5BF https://euronoxxmedical.com/
